뉴스벤징가
ResMed Analyst Backs Portfolio Reset
· 발표
기사 요약
ResMed is selling MatrixCare for $490 million to sharpen its sleep health focus as analysts weigh near-term EPS dilution against long-term growth.
기사 원문에서 발췌했어요.뉴스 본문을 불러오고 있어요.
ResMed is selling MatrixCare for $490 million to sharpen its sleep health focus as analysts weigh near-term EPS dilution against long-term growth.
기사 원문에서 발췌했어요.
댓글 —
댓글을 불러오고 있어요…